These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22891358)

  • 21. Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
    Sano K; Ichikawa T; Motosugi U; Ichikawa S; Morisaka H; Enomoto N; Matsuda M; Fujii H
    Eur Radiol; 2017 Feb; 27(2):518-525. PubMed ID: 27255397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newly developed hypervascular hepatocellular carcinoma during follow-up periods in patients with chronic liver disease: observation in serial gadoxetic acid-enhanced MRI.
    Yamamoto A; Ito K; Tamada T; Higaki A; Kanki A; Sato T; Tanimoto D
    AJR Am J Roentgenol; 2013 Jun; 200(6):1254-60. PubMed ID: 23701061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression.
    Öcal O; Zech CJ; Fabritius MP; Loewe C; van Delden O; Vandecaveye V; Gebauer B; Berg T; Sengel C; Bargellini I; Iezzi R; Benito A; Pech M; Gasbarrini A; Sangro B; Malfertheiner P; Ricke J; Seidensticker M
    Eur Radiol; 2023 Jan; 33(1):493-500. PubMed ID: 35881180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.
    Inoue T; Hyodo T; Murakami T; Takayama Y; Nishie A; Higaki A; Korenaga K; Sakamoto A; Osaki Y; Aikata H; Chayama K; Suda T; Takano T; Miyoshi K; Koda M; Numata K; Tanaka H; Iijima H; Ochi H; Hirooka M; Imai Y; Kudo M
    Dig Dis; 2013; 31(5-6):472-9. PubMed ID: 24281023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.
    Kwon HJ; Byun JH; Kim JY; Hong GS; Won HJ; Shin YM; Kim PN
    Abdom Imaging; 2015 Jan; 40(1):64-75. PubMed ID: 24997560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
    Kim HS; Kim SH; Kang TW; Song KD; Choi D; Park CK
    Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
    Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
    Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas.
    Cho YK; Kim JW; Kim MY; Cho HJ
    Gut Liver; 2018 Jan; 12(1):79-85. PubMed ID: 28798287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?
    Schmid-Tannwald C; Thomas S; Ivancevic MK; Dahi F; Rist C; Sethi I; Oto A
    Acta Radiol; 2014 Jun; 55(5):515-23. PubMed ID: 23986455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
    Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
    J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
    Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K
    Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
    Eur J Radiol; 2012 Dec; 81(12):3839-45. PubMed ID: 22884705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in cirrhosis or chronic hepatitis: incidence and predictive factors for hypervascular transformation, preliminary results.
    Higaki A; Ito K; Tamada T; Teruki S; Yamamoto A; Higashi H; Kanki A; Sato T; Noda Y
    J Magn Reson Imaging; 2013 Jun; 37(6):1377-83. PubMed ID: 23172841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.
    Di Pietropaolo M; Briani C; Federici GF; Marignani M; Begini P; Delle Fave G; Iannicelli E
    Clin Imaging; 2015; 39(3):468-75. PubMed ID: 25748089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
    Choi D; Mitchell DG; Verma SK; Bergin D; Navarro VJ; Malliah AB; McGowan C; Hann HW; Herrine SK
    Radiology; 2007 Sep; 244(3):776-83. PubMed ID: 17690322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypovascular hypointense nodules on hepatocyte phase gadoxetic acid-enhanced MR images: too early or too progressed to determine hypervascularity.
    Motosugi U
    Radiology; 2013 Apr; 267(1):317-8. PubMed ID: 23525722
    [No Abstract]   [Full Text] [Related]  

  • 37. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
    Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K
    Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Park HJ; Lee TY; Kim SY; Kim MJ; Singal AG; Lee SJ; Won HJ; Byun JH; Lim YS
    Eur Radiol; 2022 Aug; 32(8):5064-5074. PubMed ID: 35229195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.